Efficacy and Safety of Cagrilintide s.c. 2.4 Milligram (mg) in Combination With Semaglutide Subcutaneous (s.c). 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity

Status: Recruiting
Location: See all (218) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

This study has 2 parts: First part is the main study and second part is the extension study. During the main study participants will receive 1 of 4 study medicines. If participants continue in the extension study, they will not receive any study medicine during the extension. The main study will look at how well CagriSema helps participants with excess body weight lose weight compared to a dummy medicine and 2 other medicines, cagrilintide and semaglutide. Participants will either get CagriSema, cagrilintide,semaglutide or dummy medicine. Which treatment participants get is decided by chance. They will take one injection once a week. The study medicine is injected briefly with a thin needle, typically in the stomach, thighs or upper arms. Extension study: After the main study, not all participants will continue in the extension study. The study staff will tell the participant if they will continue or not into the extension study. In the extension study we will look at what happens to the participant's body weight and diseases related to excess body weight after the participant stops taking the study medicine. The main study will last for about 1½ years and the extension study will last for another 2 years.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: No
View:

• Male or female

• Age above or equal to 18 years at the time of signing informed consent

• Body mass index (BMI) greater than or equal to 30.0 kilograms per square meter (kg/m^2) or b) BMI greater than or equal to 27.0 kg/m^2 with the presence of at least one weight-related comorbidity including, but not limited to hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease

Locations
United States
Alabama
Novo Nordisk Investigational Site
Recruiting
Birmingham
California
Novo Nordisk Investigational Site
Recruiting
Los Angeles
Colorado
Novo Nordisk Investigational Site
Recruiting
Aurora
Novo Nordisk Investigational Site
Recruiting
Golden
Florida
Novo Nordisk Investigational Site
Recruiting
Fleming Island
Novo Nordisk Investigational Site
Recruiting
Orlando
Novo Nordisk Investigational Site
Recruiting
Orlando
Novo Nordisk Investigational Site
Recruiting
Pembroke Pines
Novo Nordisk Investigational Site
Recruiting
Plantation
Georgia
Novo Nordisk Investigational Site
Recruiting
Conyers
Hawaii
Novo Nordisk Investigational Site
Recruiting
Honolulu
Illinois
Novo Nordisk Investigational Site
Recruiting
Chicago
Novo Nordisk Investigational Site
Recruiting
Skokie
Indiana
Novo Nordisk Investigational Site
Recruiting
Indianapolis
Michigan
Novo Nordisk Investigational Site
Recruiting
Buckley
Missouri
Novo Nordisk Investigational Site
Recruiting
Saint Peters
North Carolina
Novo Nordisk Investigational Site
Recruiting
Chapel Hill
Novo Nordisk Investigational Site
Recruiting
Greensboro
Novo Nordisk Investigational Site
Recruiting
Greensboro
Novo Nordisk Investigational Site
Recruiting
Raleigh
Novo Nordisk Investigational Site
Recruiting
Wilmington
New York
Novo Nordisk Investigational Site
Recruiting
New York
Novo Nordisk Investigational Site
Recruiting
Vestal
Ohio
Novo Nordisk Investigational Site
Recruiting
Wadsworth
Oklahoma
Novo Nordisk Investigational Site
Recruiting
Norman
Pennsylvania
Novo Nordisk Investigational Site
Recruiting
Philadelphia
Rhode Island
Novo Nordisk Investigational Site
Recruiting
Cumberland
South Carolina
Novo Nordisk Investigational Site
Not yet recruiting
Charleston
Novo Nordisk Investigational Site
Recruiting
North Charleston
Novo Nordisk Investigational Site
Recruiting
Simpsonville
Novo Nordisk Investigational Site
Recruiting
Spartanburg
Tennessee
Novo Nordisk Investigational Site
Recruiting
Bristol
Novo Nordisk Investigational Site
Recruiting
Kingsport
Texas
Novo Nordisk Investigational Site
Recruiting
Dallas
Novo Nordisk Investigational Site
Recruiting
Dallas
Novo Nordisk Investigational Site
Recruiting
Dallas
Novo Nordisk Investigational Site
Recruiting
Longview
Virginia
Novo Nordisk Investigational Site
Recruiting
Arlington
Novo Nordisk Investigational Site
Recruiting
Newport News
Novo Nordisk Investigational Site
Recruiting
Winchester
Washington
Novo Nordisk Investigational Site
Recruiting
Olympia
Novo Nordisk Investigational Site
Recruiting
Renton
Other Locations
Argentina
Novo Nordisk Investigational Site
Recruiting
Caba
Novo Nordisk Investigational Site
Recruiting
Caba
Novo Nordisk Investigational Site
Not yet recruiting
Ciudad De Buenos Aires
Novo Nordisk Investigational Site
Not yet recruiting
Santa Rosa
Novo Nordisk Investigational Site
Not yet recruiting
Santiago Del Estero
Australia
Novo Nordisk Investigational Site
Not yet recruiting
Brookvale
Novo Nordisk Investigational Site
Recruiting
Darlinghurst
Novo Nordisk Investigational Site
Recruiting
Kotara
Novo Nordisk Investigational Site
Not yet recruiting
Taringa
Belgium
Novo Nordisk Investigational Site
Not yet recruiting
Bonheiden
Novo Nordisk Investigational Site
Not yet recruiting
Boussu
Novo Nordisk Investigational Site
Not yet recruiting
Bruxelles
Novo Nordisk Investigational Site
Not yet recruiting
Edegem
Novo Nordisk Investigational Site
Not yet recruiting
Gent
Novo Nordisk Investigational Site
Not yet recruiting
Leuven
Bulgaria
Novo Nordisk Investigational Site
Not yet recruiting
Blagoevgrad
Novo Nordisk Investigational Site
Not yet recruiting
Dupnitsa
Novo Nordisk Investigational Site
Not yet recruiting
Montana
Novo Nordisk Investigational Site
Recruiting
Pleven
Novo Nordisk Investigational Site
Recruiting
Plovdiv
Novo Nordisk Investigational Site
Not yet recruiting
Ruse
Novo Nordisk Investigational Site
Not yet recruiting
Smolyan
Novo Nordisk Investigational Site
Recruiting
Sofia
Novo Nordisk Investigational Site
Not yet recruiting
Sofia
Novo Nordisk Investigational Site
Not yet recruiting
Sofia
Novo Nordisk Investigational Site
Not yet recruiting
Sofia
Novo Nordisk Investigational Site
Not yet recruiting
Varna
Novo Nordisk Investigational Site
Not yet recruiting
Yambol
Canada
Novo Nordisk Investigational Site
Not yet recruiting
Edmonton
Novo Nordisk Investigational Site
Recruiting
Halifax
Novo Nordisk Investigational Site
Recruiting
Hamilton
Novo Nordisk Investigational Site
Recruiting
Moncton
Novo Nordisk Investigational Site
Not yet recruiting
Sherwood Park
Novo Nordisk Investigational Site
Recruiting
Surrey
Novo Nordisk Investigational Site
Not yet recruiting
Victoria
Denmark
Novo Nordisk Investigational Site
Not yet recruiting
Aarhus N
Novo Nordisk Investigational Site
Not yet recruiting
Esbjerg
Novo Nordisk Investigational Site
Recruiting
Hellerup
Novo Nordisk Investigational Site
Recruiting
Hvidovre
Novo Nordisk Investigational Site
Recruiting
Køge
Finland
Novo Nordisk Investigational Site
Not yet recruiting
Helsinki
Novo Nordisk Investigational Site
Recruiting
Kuopio
Novo Nordisk Investigational Site
Recruiting
Oulu
Novo Nordisk Investigational Site
Not yet recruiting
Turku
France
Novo Nordisk Investigational Site
Not yet recruiting
Paris Cedex 13
Novo Nordisk Investigational Site
Not yet recruiting
Pierre Benite
Novo Nordisk Investigational Site
Not yet recruiting
Saint Herblain
Novo Nordisk Investigational Site
Not yet recruiting
Strasbourg
Novo Nordisk Investigational Site
Not yet recruiting
Venissieux
Germany
Novo Nordisk Investigational Site
Not yet recruiting
Bad Mergentheim
Novo Nordisk Investigational Site
Not yet recruiting
Elsterwerda
Novo Nordisk Investigational Site
Not yet recruiting
Essen
Novo Nordisk Investigational Site
Not yet recruiting
Hamburg
Novo Nordisk Investigational Site
Not yet recruiting
Leipzig
Novo Nordisk Investigational Site
Not yet recruiting
Leipzig
Novo Nordisk Investigational Site
Not yet recruiting
Münster
Novo Nordisk Investigational Site
Not yet recruiting
Stuttgart
Novo Nordisk Investigational Site
Not yet recruiting
Wangen
India
Novo Nordisk Investigational Site
Not yet recruiting
Belgaum
Novo Nordisk Investigational Site
Not yet recruiting
Chandigarh
Novo Nordisk Investigational Site
Not yet recruiting
Delhi
Novo Nordisk Investigational Site
Not yet recruiting
Delhi
Novo Nordisk Investigational Site
Not yet recruiting
Hyderabad
Novo Nordisk Investigational Site
Not yet recruiting
Hyderabad
Novo Nordisk Investigational Site
Not yet recruiting
Jaipur
Novo Nordisk Investigational Site
Not yet recruiting
Jaipur
Novo Nordisk Investigational Site
Not yet recruiting
Kozhikode
Novo Nordisk Investigational Site
Not yet recruiting
Mumbai
Novo Nordisk Investigational Site
Not yet recruiting
Mumbai
Novo Nordisk Investigational Site
Not yet recruiting
Nagpur
Novo Nordisk Investigational Site
Not yet recruiting
Pune
Novo Nordisk Investigational Site
Not yet recruiting
Pune
Novo Nordisk Investigational Site
Not yet recruiting
Pune
Novo Nordisk Investigational Site
Not yet recruiting
Surat
Novo Nordisk Investigational Site
Not yet recruiting
Vellore
Italy
Novo Nordisk Investigational Site
Not yet recruiting
Arezzo
Novo Nordisk Investigational Site
Not yet recruiting
Bari
Novo Nordisk Investigational Site
Not yet recruiting
Bologna
Novo Nordisk Investigational Site
Not yet recruiting
Catania
Novo Nordisk Investigational Site
Not yet recruiting
Catanzaro
Novo Nordisk Investigational Site
Not yet recruiting
Padova
Novo Nordisk Investigational Site
Not yet recruiting
Partinico
Novo Nordisk Investigational Site
Not yet recruiting
Roma
Novo Nordisk Investigational Site
Not yet recruiting
Roma
Novo Nordisk Investigational Site
Not yet recruiting
Roma
Novo Nordisk Investigational Site
Not yet recruiting
Siena
Japan
Novo Nordisk Investigational Site
Recruiting
Aichi
Novo Nordisk Investigational Site
Not yet recruiting
Chiba-shi, Chiba
Novo Nordisk Investigational Site
Recruiting
Gunma
Novo Nordisk Investigational Site
Recruiting
Kanagawa
Novo Nordisk Investigational Site
Recruiting
Osaka
Novo Nordisk Investigational Site
Recruiting
Saitama
Novo Nordisk Investigational Site
Recruiting
Sapporo City, Hokkaido
Novo Nordisk Investigational Site
Recruiting
Sendai-shi, Miyagi
Novo Nordisk Investigational Site
Recruiting
Suita-shi, Osaka
Novo Nordisk Investigational Site
Recruiting
Tokyo
Novo Nordisk Investigational Site
Recruiting
Tokyo
Novo Nordisk Investigational Site
Recruiting
Tokyo
Novo Nordisk Investigational Site
Recruiting
Tokyo
Novo Nordisk Investigational Site
Recruiting
Tokyo
Mexico
Novo Nordisk Investigational Site
Not yet recruiting
Aguascalientes
Novo Nordisk Investigational Site
Not yet recruiting
Guadalajara
Novo Nordisk Investigational Site
Not yet recruiting
Guadalajara
Novo Nordisk Investigational Site
Not yet recruiting
Monterrey
Novo Nordisk Investigational Site
Not yet recruiting
Monterrey
Netherlands
Novo Nordisk Investigational Site
Recruiting
Amsterdam
Novo Nordisk Investigational Site
Recruiting
Arnhem
Novo Nordisk Investigational Site
Not yet recruiting
Hoofddorp
Novo Nordisk Investigational Site
Not yet recruiting
Roosendaal
Novo Nordisk Investigational Site
Not yet recruiting
Zwijndrecht
Poland
Novo Nordisk Investigational Site
Recruiting
Bialystok
Novo Nordisk Investigational Site
Recruiting
Bialystok
Novo Nordisk Investigational Site
Withdrawn
Bydgoszcz
Novo Nordisk Investigational Site
Recruiting
Bygdoszcz
Novo Nordisk Investigational Site
Recruiting
Elblag
Novo Nordisk Investigational Site
Not yet recruiting
Gdansk
Novo Nordisk Investigational Site
Recruiting
Katowice
Novo Nordisk Investigational Site
Recruiting
Krakow
Novo Nordisk Investigational Site
Not yet recruiting
Legnica
Novo Nordisk Investigational Site
Recruiting
Lublin
Novo Nordisk Investigational Site
Recruiting
Poznan
Novo Nordisk Investigational Site
Not yet recruiting
Poznań
Novo Nordisk Investigational Site
Recruiting
Warszawa
Novo Nordisk Investigational Site
Not yet recruiting
Warszawa
Republic of Korea
Novo Nordisk Investigational Site
Not yet recruiting
Bucheon-si
Novo Nordisk Investigational Site
Not yet recruiting
Daegu
Novo Nordisk Investigational Site
Not yet recruiting
Daejeon
Novo Nordisk Investigational Site
Not yet recruiting
Incheon
Novo Nordisk Investigational Site
Not yet recruiting
Seongnam-si, Gyeonggi-do
Novo Nordisk Investigational Site
Not yet recruiting
Seoul
Novo Nordisk Investigational Site
Not yet recruiting
Seoul
Novo Nordisk Investigational Site
Not yet recruiting
Seoul
Novo Nordisk Investigational Site
Not yet recruiting
Seoul
Novo Nordisk Investigational Site
Not yet recruiting
Yangsan
Serbia
Novo Nordisk Investigational Site
Not yet recruiting
Belgrade
Novo Nordisk Investigational Site
Not yet recruiting
Belgrade
Novo Nordisk Investigational Site
Not yet recruiting
Novi Sad
South Africa
Novo Nordisk Investigational Site
Recruiting
Brits
Novo Nordisk Investigational Site
Not yet recruiting
Cape Town
Novo Nordisk Investigational Site
Not yet recruiting
Durban
Novo Nordisk Investigational Site
Not yet recruiting
Durban
Novo Nordisk Investigational Site
Not yet recruiting
Johannesburg
Novo Nordisk Investigational Site
Not yet recruiting
Johannesburg
Novo Nordisk Investigational Site
Recruiting
Lenasia
Novo Nordisk Investigational Site
Not yet recruiting
Midrand
Novo Nordisk Investigational Site
Not yet recruiting
Pretoria
Spain
Novo Nordisk Investigational Site
Not yet recruiting
Barcelona
Novo Nordisk Investigational Site
Not yet recruiting
Castilleja Dela Cuesta Sevilla
Novo Nordisk Investigational Site
Not yet recruiting
León
Novo Nordisk Investigational Site
Not yet recruiting
Madrid
Novo Nordisk Investigational Site
Not yet recruiting
Pamplona
Novo Nordisk Investigational Site
Not yet recruiting
Sevilla
Novo Nordisk Investigational Site
Not yet recruiting
Sevilla
Taiwan
Novo Nordisk Investigational Site
Not yet recruiting
Taichung
Novo Nordisk Investigational Site
Recruiting
Taipei City
Turkey
Novo Nordisk Investigational Site
Not yet recruiting
Adana
Novo Nordisk Investigational Site
Not yet recruiting
Adana
Novo Nordisk Investigational Site
Not yet recruiting
Ankara
Novo Nordisk Investigational Site
Not yet recruiting
Antalya
Novo Nordisk Investigational Site
Not yet recruiting
Hatay
Novo Nordisk Investigational Site
Not yet recruiting
Istanbul
Novo Nordisk Investigational Site
Not yet recruiting
Istanbul
Novo Nordisk Investigational Site
Not yet recruiting
Istanbul
Novo Nordisk Investigational Site
Not yet recruiting
Istanbul
United Kingdom
Novo Nordisk Investigational Site
Recruiting
Blackpool
Novo Nordisk Investigational Site
Recruiting
Bristol
Novo Nordisk Investigational Site
Not yet recruiting
Cambridge
Novo Nordisk Investigational Site
Recruiting
Chester
Novo Nordisk Investigational Site
Recruiting
Chippenham
Novo Nordisk Investigational Site
Not yet recruiting
Coventry
Novo Nordisk Investigational Site
Recruiting
Liverpool
Novo Nordisk Investigational Site
Not yet recruiting
London
Novo Nordisk Investigational Site
Not yet recruiting
London
Novo Nordisk Investigational Site
Not yet recruiting
London
Novo Nordisk Investigational Site
Recruiting
Orpington
Novo Nordisk Investigational Site
Recruiting
Taunton
Contact Information
Primary
Novo Nordisk
clinicaltrials@novonordisk.com
(+1) 866-867-7178
Time Frame
Start Date: November 1, 2022
Estimated Completion Date: October 19, 2026
Participants
Target number of participants: 3400
Treatments
Experimental: Cagrisema s.c. 2.4 mg/2.4 mg
Participants will receive 2.4 mg cagrilintide and 2.4 mg semaglutide once-weekly after a dose escalation period of 16 weeks (0.25 mg of cagrilintide and 0.25 mg of semaglutide from weeks 0-4, 0.5 mg of cagrilintide and 0.5 mg of semaglutide from weeks 5-8, 1 mg of cagrilintide and 1 mg of semaglutide from weeks 9-12 and 1.7 mg of cagrilintide and 1.7 mg of semaglutide from weeks 13-16) during the maintenance period for 52 weeks in the main phase. Participants randomised to this arm will be included in the extension phase for 97 weeks.
Active Comparator: Cagrilintide s.c. 2.4 mg
Participants will receive cagrilintide s.c. 2.4 mg and placebo matching to semaglutide once-weekly after a dose escalation period of 16 weeks (0.25 mg for weeks 0-4, 0.5 mg for weeks 5-8, 1 mg for weeks 9-12 and 1.7 mg for weeks 13-16) during the maintenance period for 52 weeks.
Active Comparator: Semaglutide s.c. 2.4 mg
Participants will receive semaglutide s.c. 2.4 mg and placebo matched to cagrilintide once-weekly after a dose escalation period of 16 weeks (0.25 mg for weeks 0-4, 0.5 mg for weeks 5-8, 1 mg for weeks 9-12 and 1.7 mg for weeks 13-16) during the maintenance period for 52 weeks.
Placebo Comparator: Placebo s.c.
Participants will receive placebo matched to cagrilintide and placebo matched to semaglutide once weekly for 68 weeks. Participants randomised to this arm will be included in the extension phase for 97 weeks.
Related Therapeutic Areas
Sponsors
Leads: Novo Nordisk A/S

This content was sourced from clinicaltrials.gov

Similar Clinical Trials